X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56) 56
oncology (55) 55
humans (42) 42
article (35) 35
cancer (29) 29
mutation (28) 28
female (24) 24
lung neoplasms - genetics (21) 21
tumors (20) 20
lung cancer (18) 18
male (18) 18
middle aged (18) 18
aged (17) 17
lung neoplasms - drug therapy (16) 16
crizotinib (15) 15
respiratory system (13) 13
adenocarcinoma - genetics (12) 12
adenocarcinoma of lung (12) 12
open-label (12) 12
patients (12) 12
solid tumors (12) 12
adult (11) 11
aged, 80 and over (11) 11
alk (11) 11
antineoplastic agents - therapeutic use (11) 11
mutations (11) 11
carcinoma, non-small-cell lung - drug therapy (10) 10
chemotherapy (10) 10
lung neoplasms - pathology (10) 10
molecular targeted therapy (10) 10
neoplasms - drug therapy (10) 10
care and treatment (9) 9
lung cancer, non-small cell (9) 9
protein kinase inhibitors - therapeutic use (9) 9
cell lung-cancer (8) 8
genetic aspects (8) 8
kinases (8) 8
neoplasms - genetics (8) 8
acquired-resistance (7) 7
adenocarcinoma (7) 7
carcinoma, non-small-cell lung - genetics (7) 7
entrectinib (7) 7
expression (7) 7
identification (7) 7
metastasis (7) 7
proto-oncogene proteins c-ret - genetics (7) 7
ros1 (7) 7
targeted therapy (7) 7
treatment outcome (7) 7
tyrosine (7) 7
animals (6) 6
cabozantinib (6) 6
clinical trials (6) 6
fusions (6) 6
gene fusion (6) 6
health aspects (6) 6
hematology, oncology and palliative medicine (6) 6
lung neoplasms - enzymology (6) 6
medical research (6) 6
proto-oncogene proteins - genetics (6) 6
rearrangements (6) 6
adenocarcinoma - drug therapy (5) 5
adenocarcinoma - pathology (5) 5
adenocarcinomas (5) 5
adolescent (5) 5
antineoplastic agents - pharmacology (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
biomarkers, tumor - genetics (5) 5
cancer therapies (5) 5
carcinoma (5) 5
cell line, tumor (5) 5
erbb receptors - genetics (5) 5
gefitinib (5) 5
gene (5) 5
gene mutations (5) 5
gene rearrangement (5) 5
inhibition (5) 5
lung adenocarcinoma (5) 5
next-generation sequencing (5) 5
non-small cell lung cancer (5) 5
receptor, trka - genetics (5) 5
resistance (5) 5
tyrosine kinase inhibitor (5) 5
vandetanib (5) 5
adenocarcinoma - enzymology (4) 4
analysis (4) 4
anaplastic lymphoma kinase (4) 4
breast-cancer (4) 4
carboplatin (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
drug dosages (4) 4
fusion (4) 4
growth-factor receptor (4) 4
inhibitors (4) 4
kinase (4) 4
kras mutations (4) 4
landscape (4) 4
neoplasm staging (4) 4
neoplasms - pathology (4) 4
nsclc (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Book
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2832 - 2834
Journal Article
Journal Article
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2016, Volume 5, Issue 1, pp. 5 - 6
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 8, pp. 731 - 739
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7691, pp. 189 - 194
Journal Article
Lung Cancer, ISSN 0169-5002, 11/2019, Volume 137, pp. 113 - 122
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 80–85% of cases. Epidermal growth factor receptor (EGFR) mutations... 
Exon 19 deletion | Exon 21 mutation | Tyrosine kinase inhibitor | Sequencing | Epidermal growth factor receptor | Non-small cell lung cancer
Journal Article